I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old
This phase II trial studies how well liposome-encapsulated daunorubicin-cytarabine (CPX-351) works in treating patients with secondary acute myeloid leukemia who are younger than 60 years old. Drugs used in chemotherapy, such as CPX-351, work in different ways to stop the growth of cancer cells, either by killing the cells, by …
ejection fraction
chronic myelomonocytic leukemia
myeloid leukemia
treatment related acute myeloid leukemia
plasma creatinine
- 0 views
- 19 Feb, 2024